AC Immune (ACIU) Non-Current Assets (2014 - 2025)

AC Immune (ACIU) has 12 years of Non-Current Assets data on file, last reported at $72.0 million in Q4 2025.

• Quarterly Non-Current Assets rose 7.02% year-over-year to $72.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $72.0 million (up 7.02% YoY) and the FY2025 annual result came in at $69.4 million, up 3.17% from the prior year.
• Non-Current Assets steadied at $72.0 million in Q4 2025 per ACIU's latest filing, from $72.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $65.0 billion in Q4 2023 and bottomed at $8.7 million in Q3 2021.
• The 5-year median for Non-Current Assets is $65.5 million (2024), against an average of $7.4 billion.
• The widest annual swing landed in 2021, when Non-Current Assets soared 826772.02%; it then slumped 99.91% in 2022.
• Tracing ACIU's Non-Current Assets over 5 years: stood at $63.8 billion in 2021, then tumbled by 99.91% to $60.0 million in 2022, then soared by 108162.44% to $65.0 billion in 2023, then tumbled by 99.9% to $67.3 million in 2024, then climbed by 7.02% to $72.0 million in 2025.
• Per Business Quant, the three latest ACIU Non-Current Assets figures stand at $72.0 million (Q4 2025), $72.3 million (Q3 2025), and $70.6 million (Q2 2025).

Peer Comparison